 |
Glycemic
Control in Type 2 Diabetes: Time for an Evidence-Based About-Face? |
| |
Our review and critique of recent large randomized
trials in patients with type 2 diabetes suggest that tight glycemic
control burdens patients with complex treatment programs, hypoglycemia,
weight gain, and costs and offers uncertain benefits in return
(Annals of Internal Medicine) |
| |
|
|
UK
researchers make breakthrough in immune system therapy |
| |
JDRF funded researchers at King’s
College London and the University of Bristol have shown that a
potential immune system therapy for type 1 diabetes is safe. Peptide
immunotherapy is a type of treatment that uses small proteins to ‘reset’ the immune system to a healthy state, much like an allergy jab (JDRF) |
| |
|
|
Long-term
effects of diabetes during pregnancy on the offspring |
| |
Children born to mothers with gestational diabetes
seem to be at risk for obesity and metabolic disturbances (Pediatric
Diabetes) |
| |
|
|
Peri-Conceptional
A1C and Risk of Serious Adverse Pregnancy Outcome in 933 Women
With Type 1 Diabetes |
| |
These results support recent guidelines of preconceptional
A1C levels <7% in women with type 1 diabetes (Diabetes Care) |
| |
|
